MBX Biosciences, Inc.
Developing novel peptide therapies for underserved endocrine and metabolic disorders.
MBX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11711 N. MERIDIAN STREET, 46032 CARMEL
- Website:
- https://mbxbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for endocrine and metabolic disorders. The company pioneers a proprietary platform of Precision Endocrine Peptides (PEPs)™, designed to create transformative treatments for underserved patient populations. By advancing its growing pipeline of PEP candidates, including those for conditions like hypoparathyroidism, MBX Biosciences aims to overcome the limitations of existing therapeutics, simplify disease management, and deliver improved health outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MBX Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MBX Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MBX Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
